Valuation: Norda ASA

Market Cap 513M 53.02M 46.47M 42.95M 39.5M 74.54M 5.11B 75.73M 514M 201M 2.5B 199M 195M 8.62B P/E 2023 *
-
P/E 2024 3.26x
Enterprise Value 264M 27.31M 23.94M 22.13M 20.35M 38.4M 2.63B 39.01M 265M 104M 1.29B 103M 100M 4.44B EV / Sales 2023
-1.24x
EV / Sales 2024 0.4x
Free-Float
6.26%
Yield 2023 *
-
Yield 2024 32.5%
Manager TitleAgeSince
Chief Executive Officer - 2013-04-07
Director TitleAgeSince
Chairman 54 2014-01-30
Director/Board Member 68 2013-06-19
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+3.37%-6.12% - - 46M
-0.49%-4.01%-0.84%+2.28% 49.18B
-3.10%-1.94%+370.99%+572.60% 39.58B
-0.46%+2.18%+5.44%+61.01% 34.69B
-1.14%-1.76%+26.94%-9.93% 34.42B
-1.82%-1.43%+0.52%+31.85% 27.11B
-3.54%-5.08% - - 16.21B
-1.82%-0.43%+69.28%+113.82% 15.36B
+1.17%+2.30%+15.87%+18.26% 14.05B
-2.25%+0.05%+15.77%-32.83% 13.02B
Average -1.01%-0.85%+63.00%+94.63% 27.07B
Weighted average by Cap. -1.43%-1.02%+75.91%+118.68%

Financials

2023 2024
Net sales 86.92M 8.98M 7.87M 7.28M 6.69M 12.63M 866M 12.83M 86.99M 34.1M 424M 33.72M 32.98M 1.46B 372M 38.42M 33.67M 31.12M 28.63M 54.01M 3.7B 54.88M 372M 146M 1.81B 144M 141M 6.24B
Net income 31.17M 3.22M 2.82M 2.61M 2.4M 4.53M 311M 4.6M 31.2M 12.23M 152M 12.09M 11.83M 524M 126M 13.01M 11.4M 10.54M 9.7M 18.29M 1.25B 18.59M 126M 49.41M 614M 48.86M 47.79M 2.12B
Net Debt -311M -32.15M -28.18M -26.05M -23.96M -45.21M -3.1B -45.93M -312M -122M -1.52B -121M -118M -5.23B -249M -25.71M -22.53M -20.83M -19.15M -36.14M -2.48B -36.72M -249M -97.62M -1.21B -96.52M -94.42M -4.18B
Logo Norda ASA
Norda ASA, formerly NorDiag ASA, is a Norway-based company active within the biotechnology sector. It develops, manufactures and markets automated solutions (instruments and tests) for sample preparation of bacterial and human DNA from difficult biological samples for use in the fields of infectious diseases, transplantation testing (HLA Typing) and others. The Company’s products include NorDiag Arrow (CE, IVD), which is a compact, automated solution for nucleic acid extractions, as well as NorDiag Bullet, 8 tip config, which is a fully automated sample preparation instrument for molecular diagnostics and can isolate from samples such as urine, swab, faces, sputum and blood. Its distribution products include Molzym GmbH and Co KG, as well as Hain Lifescience GmbH. Its customers are clinical laboratories, hospitals, research institutes, medical diagnostics and healthcare providers. It is operational through offices and laboratories in Norway, Sweden, Austria and the United States.
Employees
-